To address the degradation of rechargeable batteries, this paper presents a two-phase gamma process model with a fixed change-point for modeling the voltage-discharge curves of battery cycle aging under a constant current. The model can be applied to estimate the state of charge (SOC) and the remaining useful discharge time (RUT) in a cycle with consideration of the effect of cycle aging, and can also be applied to estimate the state of life (SOL) and the remaining useful life (RUL) across cycles. The applications of the proposed model are demonstrated using the experimental cycle aging data of a lithium iron phosphate battery. A comparison shows that the proposed model generates a more accurate prediction than the conventional two-term exponential model with capacity data under a particle filter framework, and this reveals the superiority of modeling with voltage over modeling with capacity. The analytical expression of mean useful discharge time in a cycle (or mean time to failure) is developed with approximation by a Taylor expansion and the Birnbaum-Saunders distribution, and the result is shown to be in good agreement with the true mean of a gamma process.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294100 | PMC |
http://dx.doi.org/10.1016/j.ress.2021.107797 | DOI Listing |
Sci Rep
December 2024
Departamento de Astronomía, Universidad de Chile, Casilla 36-D, Santiago, Chile.
Multiple physiological traits correlates with lifespan, being unclear both the causal connection among them and with the process of ageing. In this paper, we show that six traits (such as metabolic rate, mass, heart rate, etc) acting at the system level, are all related to lifespan thru the existence of an approximately constant number of respiration cycles in a lifespan ([Formula: see text]), therefore, we find that those relationships are not independently related to ageing. In addition, we study if the approximately constant [Formula: see text] is possibly linked with the end-of-lifespan somatic mutation burden, another number recently found to be approximately constant (Cagan, Nature 604:517-524, 2022).
View Article and Find Full Text PDFNat Commun
December 2024
Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Accumulating evidence indicates that cellular senescence is closely associated with osteoarthritis. However, there is limited research on the mechanisms underlying fibroblast-like synoviocyte senescence and its impact on osteoarthritis progression. Here, we elucidate a positive correlation between fibroblast-like synoviocyte senescence and osteoarthritis progression and reveal that GATD3A deficiency induces fibroblast-like synoviocyte senescence.
View Article and Find Full Text PDFFront Public Health
December 2024
Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Background: An essential part of aging is menopause, which indicates the final phase of the female reproductive cycle. The objective of this research was to assess anxiety and depressive symptoms among menopausal women in Asir region, Saudi Arabia.
Methods: The cross-sectional survey was carried out in February to June 2024, using a random sampling procedure, study participants were selected.
Open Vet J
November 2024
Theriogenology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Background: Senility influences fertility in women and companion animals, especially horses.
Aim: This study aimed to investigate the effect of aging in horses on the daily changes in the dominant follicle (DF) dynamics and hemodynamics, antimüllerian hormone (AMH), enzymes, antioxidants, and ovarian hormones during the estrous cycle.
Methods: Ovaries of old mares ( = 5, age >20 years) and young native mares ( = 6, age <10 years) were scanned during 6 different estrous cycles from March 2022 to August 2023 with Doppler ultrasound.
J Exp Clin Cancer Res
December 2024
Institute for Research On Cancer and Aging of Nice (IRCAN), CNRS UMR 7284, INSERM U1081, University Côte d'Azur, Nice, France.
Background: Multiple Myeloma (MM) is the second most common hematological malignancy, characterized by the accumulation of monoclonal plasmocytes in the bone marrow. Despite advancements with proteasome inhibitors, immunomodulatory agents, and CD38-targeting antibodies, MM remains largely incurable due to resistant clones and frequent relapses. The success of the proteasome inhibitor bortezomib (BTZ) in MM treatment highlights the critical role of the ubiquitin-proteasome system (UPS) in this disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!